Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

Medicus Pharma Ltd ( ($MDCX) ) has shared an announcement. Medicus Pharma Ltd. announced its participation in the Family Office Summit in Dubai, ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth ...

The ground shifted under China’s drugmakers when volume-based procurement cut through list prices. Margins tightened, ...

Biotech is outperforming the S&P 500 and NASDAQ as M&A heats up and Q4 tailwinds emerge, signaling more upside ahead. Read ...

Adam is out this week, so Allison and Elaine dive into the latest news, starting with another biotech acquisition and a new ...

Biotech startup has raised nearly $200 million in venture money and is planning clinical trials for a muscular dystrophy ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...

Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best biotech stocks with high potential. In a report released on ...

Regulators focused on pragmatic safety messaging this week, with aligned statements that paracetamol remains appropriate in ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

A strategic shift at ESCO toward higher-margin segments is improving profitability and resilience across its portfolio.